Alexion Pharmaceuticals was a global biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing life-transforming therapies for rare diseases. Founded in 1992, the company pioneered complement inhibition therapy and developed leading treatments for rare hematological and neurological conditions including Soliris… - View it on GitHub